BRIEF-Genmab announces preliminary cervical cancer data from tisotumab vedotin phase I/II study By: Reuters: Company News June 16, 2017 at 13:43 PM EDT * Genmab announces preliminary cervical cancer data from tisotumab vedotin phase i/ii study Read More >> Related Stocks: Gen Digital Inc